Literature DB >> 23015073

Office evaluation of male patients with lower urinary tract symptoms.

Shahin Tabatabaei1, Saman Shafaat Talab, Mahdi Zangi, Henry H Woo.   

Abstract

Lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) are one of the most common urologic disorders in men. Accurate history-taking and focused physical examination allows us to diagnose the majority of cases. A better understanding of risk factors helps us tailor our treatment and predict outcomes more accurately. Population studies are crucial in our understanding of LUTS/BPH natural history. Temporary prostatic urethral stents that are used for the management of urinary retention may also be used for evaluation of patients with detrusor hypo-contractility. The use of ultrasound to measure intravesical prostatic protrusion (IPP) and the Doppler study for prostate capsular artery resistive index are promising. Near-infrared spectroscopy (NIRS) examines the tissue oxygenation that may be affected by bladder outlet obstruction. The mathematical algorithm needs some fine-tuning, and its reproducibility is debatable. Serum and urinary biomarkers may help us to diagnose the disorder, and more effectively monitor patients' response to therapy. Among all, IPP is clinically more applicable at this time.

Entities:  

Mesh:

Year:  2012        PMID: 23015073     DOI: 10.1007/s11934-012-0283-8

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  48 in total

1.  Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume.

Authors:  John Shyi Peng Yuen; James Tan Khiaw Ngiap; Christopher Wai Sam Cheng; Keong Tatt Foo
Journal:  Int J Urol       Date:  2002-04       Impact factor: 3.369

2.  Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia.

Authors:  Hitoshi Shinbo; Yutaka Kurita; Sanki Takada; Takeshi Imanishi; Atsushi Otsuka; Hiroshi Furuse; Toshimasa Nakanishi; Soichi Mugiya; Seiichiro Ozono
Journal:  Urology       Date:  2010-06-20       Impact factor: 2.649

3.  Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.

Authors:  Joon Chul Kim; Eun Young Park; Sung Hoo Hong; Seong Il Seo; Yong Hyun Park; Tae-Kon Hwang
Journal:  Int J Urol       Date:  2005-10       Impact factor: 3.369

4.  Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia.

Authors:  Xuefeng Zhang; Gang Li; Xuedong Wei; Xiaodong Mo; Linkun Hu; Yueqin Zha; Jianquan Hou
Journal:  J Urol       Date:  2012-07-20       Impact factor: 7.450

5.  Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.

Authors:  Debra E Irwin; Zoe S Kopp; Barnabie Agatep; Ian Milsom; Paul Abrams
Journal:  BJU Int       Date:  2011-01-13       Impact factor: 5.588

6.  Evaluation and treatment of lower urinary tract symptoms in older men.

Authors:  P Abrams; C Chapple; S Khoury; C Roehrborn; J de la Rosette
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

7.  Novel biomarkers of bladder decompensation after partial bladder obstruction.

Authors:  Ahmet Guven; Carmin Kalorin; Bulent Onal; Catherine Whitbeck; Paul Chichester; Barry A Kogan; Robert M Levin; Anita Mannikarottu
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

Review 8.  Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.

Authors:  J Kellogg Parsons; Aruna V Sarma; Kevin McVary; John T Wei
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

9.  Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.

Authors:  Hsin-Tzu Liu; Hann-Chorng Kuo
Journal:  Urology       Date:  2008-04-08       Impact factor: 2.649

10.  Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.

Authors:  M Ozgür Tan; Ilhan Karabiyik; M Cemil Uygur; Yusuf Diker; Demokan Erol
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.